🇧🇪 Belgium Country × Condition
astrocytoma grade iv Clinical Trials in Belgium
Active clinical trials for astrocytoma grade iv with research sites in Belgium. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇧🇪 Belgium
Active Trials in Belgium (2)
NCT03861299
Recruiting
The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.
Enrollment
246 pts
Country
🇧🇪 Belgium
Jasper Gerritsen
View Trial → NCT06118723
Recruiting
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
Enrollment
784 pts
Country
🇧🇪 Belgium
Jasper Gerritsen
View Trial → Frequently Asked Questions
How many astrocytoma grade iv clinical trials are active in Belgium?
There are currently 2 active clinical trials for astrocytoma grade iv with sites in Belgium, of which 2 are actively recruiting patients.
How can I join a astrocytoma grade iv clinical trial in Belgium?
To join a astrocytoma grade iv clinical trial in Belgium, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Belgium directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are astrocytoma grade iv trials in Belgium?
Active astrocytoma grade iv trials in Belgium span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology